FDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics
Summary
President Donald Trump has signed an executive order to increase research on psychedelic drugs for treating mental health conditions. FDA Commissioner Marty Makary explained the order and its goals in an interview with CBS News.Key Facts
- President Trump signed an executive order focused on psychedelic drugs.
- The order aims to expand scientific research on these drugs for mental health treatment.
- Psychedelic drugs are substances that can alter perception and mood.
- The Food and Drug Administration (FDA) oversees drug approval and research in the U.S.
- Marty Makary is the current FDA Commissioner.
- Makary spoke about the executive order on CBS News.
- The goal is to explore new options for mental health care through this research.
- Mental health treatments currently have limited options, which this research hopes to improve.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
